在澳大利亚的一般实践中口服COVID-19抗病毒处方 - 一项回顾性观察性研究
Judith Thomas1, Abbish Kamalakkannan1, Mirela Prgomet1
1Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
Australian journal of primary health
|February 11, 2025
概括
分析了澳大利亚一般实践中口服COVID-19抗病毒处方的情况. 处方量可能表明COVID-19的传播,远程医疗优先用于时间关键的访问.
科学领域:
- 一般实践 一般实践
- 药理学 药理学 是一个学科.
- 公共卫生 公共卫生
背景情况:
- 澳大利亚一般实践中口服COVID-19抗病毒处方模式尚不清楚.
- 了解这些模式对于管理COVID-19和告知公共卫生战略至关重要.
研究的目的:
- 在澳大利亚的一般实践中全面分析口服COVID-19抗病毒处方.
- 确定与口服抗病毒使用相关的患者人口统计,健康特征和处方趋势.
主要方法:
- 使用非识别的澳大利亚一般实践数据进行回顾性观察队列研究 (2022年3月至2023年9月).
- 分析来自938家全科医院的咨询和处方数据,比较抗病毒和比较队列.
- 主要结局包括抗病毒频率,类型,患者特征,次要结局包括重复处方和咨询模式.
主要成果:
- 在超过380万名患者中,口服COVID-19抗病毒药物被处方给了3.39%,年龄≥70岁 (14.79%) 的患者的发病率更高.
- 莫尔努皮拉维尔的处方超过了涅马特雷尔维尔-里托纳维尔;在女性,维多利亚州,高社会经济水平地区和特定年龄组 (80-84岁) 的处方更高.
- 远程医疗咨询 (54.45%) 占比于面对面的抗病毒处方,心血管和肌肉骨疾病是最常见的慢性诊断.
结论:
- 口服COVID-19抗病毒处方量可以作为增加COVID-19传播的指标.
- 远程医疗用于处方的普遍性支持其继续用于及时获得治疗和减少暴露风险.
相关概念视频
Acute Pharyngitis
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


